Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Randomized Clinical Trial

Launched by PEDRO-JOSÉ TORRIJOS-GARRIDO · Oct 4, 2022

Keywords

ClinConnect Summary

The TIBIA3D trial is a research study looking at how 3D printing models can help in the surgical treatment of tibial plateau fractures, which are breaks in the upper part of the shinbone near the knee. The goal is to see if these detailed models can improve surgical outcomes for patients. The study is currently recruiting participants who are 18 years and older and have a tibial plateau fracture that needs surgery. However, individuals who are pregnant, have serious health issues, or other complicating fractures may not be eligible to join.

If you participate in this trial, you can expect to undergo standard surgical treatment for your fracture, with the added benefit of using a 3D printed model to guide the surgery. This model aims to make the surgery more precise and could lead to better recovery outcomes. Before you can take part, you'll need to provide written consent, confirming that you understand the study and agree to participate. This is an important step to ensure that all participants are fully informed about what the study involves.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with tibial plateau fracture requiring surgical treatment.
• • Age equal to or greater than 18 years.
• • Signature of informed consent in writing according to current legislation before collecting any information.
• Exclusion Criteria:
• • Pregnancy in progress.
• • Presence of serious systemic pathology or another situation that contraindicates treatment
• • Presence of other fractures in the ipsilateral femur or tibia that condition the surgical treatment of the tibial plateau fracture.
• • Findings in the physical examination, in the results of the tests or other medical, social or psychopathological factors that, in the opinion of the investigators, could negatively influence the study.
• • Inability to grant informed consent in the absence of a legal representative.
• • Inability to follow instructions or collaborate during the development of the study.